ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Targeting PRKCN, an Essential Driver Orchestrating mTOR-IRF4 Axis Independently of Kinase Activity, in Multiple Myeloma.
Koukou Tang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.